SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-20-008179
Filing Date
2020-03-02
Accepted
2020-03-02 16:33:20
Documents
152
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K amrx-10k_20191231.htm   iXBRL 10-K 6701398
2 EX-4.2 amrx-ex42_12.htm EX-4.2 18338
3 EX-10.12 amrx-ex1012_8.htm EX-10.12 17849
4 EX-21.1 amrx-ex211_11.htm EX-21.1 18698
5 EX-23.1 amrx-ex231_9.htm EX-23.1 6500
6 EX-31.1 amrx-ex311_16.htm EX-31.1 18459
7 EX-31.2 amrx-ex312_15.htm EX-31.2 18445
8 EX-31.3 amrx-ex313_6.htm EX-31.3 18463
9 EX-32.1 amrx-ex321_17.htm EX-32.1 9141
10 EX-32.2 amrx-ex322_18.htm EX-32.2 9114
11 EX-32.3 amrx-ex323_10.htm EX-32.3 9184
12 GRAPHIC gervt05l4p5u000001.jpg GRAPHIC 42352
  Complete submission text file 0001564590-20-008179.txt   27189188

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA amrx-20191231.xsd EX-101.SCH 144749
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE amrx-20191231_cal.xml EX-101.CAL 146545
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amrx-20191231_def.xml EX-101.DEF 609252
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrx-20191231_lab.xml EX-101.LAB 1106329
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrx-20191231_pre.xml EX-101.PRE 918255
138 EXTRACTED XBRL INSTANCE DOCUMENT amrx-10k_20191231_htm.xml XML 6392725
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38485 | Film No.: 20677364
SIC: 2834 Pharmaceutical Preparations